Physician profile
Scott Schlesinger
NPI 1114940996
$5,858.50
in general payments reported to CMS, 2019-2025
10 companies · $145 in 2025
The $145 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,692 · 2020: $2,803 · 2021: $388 · 2022: $279 · 2023: $370 · 2024: $182 · 2025: $145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $697.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $697.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Wenzel Spine, INC. | $2,883.42 | 2019-2023 | Varilift |
| Spine Wave, INC. | $1,888.60 | 2019-2022 | |
| Boston Scientific Corporation | $380.07 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Si-Bone, INC. | $180.71 | 2022 | |
| Globus Medical, INC. | $168.55 | 2021-2025 | Senza |
| Hologic Sales and Service, LLC | $139.54 | 2023 | 3dimensions, 3dquorum, Brevera Breast Biopsy System |
| Depuy Synthes Sales INC. | $124.98 | 2019 | |
| Spinal Simplicity, LLC | $50.00 | 2024 | Ha Minuteman G3-R |
| Smith+Nephew, INC. | $31.16 | 2019 | |
| Amgen INC. | $11.47 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Schlesinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.